These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 19201071)

  • 1. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
    Kreuzinger N; Clara M; Strenn B; Kroiss H
    Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece.
    Kosma CI; Lambropoulou DA; Albanis TA
    J Hazard Mater; 2010 Jul; 179(1-3):804-17. PubMed ID: 20395039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
    Boyd GR; Reemtsma H; Grimm DA; Mitra S
    Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of pharmaceuticals and personal care products contamination along the river Somes watershed, Romania.
    Moldovan Z; Schmutzer G; Tusa F; Calin R; Alder AC
    J Environ Monit; 2007 Sep; 9(9):986-93. PubMed ID: 17726560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
    Sui Q; Huang J; Deng S; Chen W; Yu G
    Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A broad spectrum analytical scheme for the screening of endocrine disruptors (EDs), pharmaceuticals and personal care products in wastewaters and natural waters.
    Bruchet A; Prompsy C; Fillppi G; Souall A
    Water Sci Technol; 2002; 46(3):97-104. PubMed ID: 12227610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants.
    Clara M; Kreuzinger N; Strenn B; Gans O; Kroiss H
    Water Res; 2005 Jan; 39(1):97-106. PubMed ID: 15607169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan.
    Lin AY; Lin CF; Tsai YT; Lin HH; Chen J; Wang XH; Yu TH
    Water Sci Technol; 2010; 62(10):2450-8. PubMed ID: 21076233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology.
    Salgado R; Noronha JP; Oehmen A; Carvalho G; Reis MA
    Water Sci Technol; 2010; 62(12):2862-71. PubMed ID: 21123916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies.
    Ort C; Lawrence MG; Reungoat J; Mueller JF
    Environ Sci Technol; 2010 Aug; 44(16):6289-96. PubMed ID: 20704228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA.
    Yu CP; Chu KH
    Chemosphere; 2009 Jun; 75(10):1281-6. PubMed ID: 19395062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review.
    Ort C; Lawrence MG; Rieckermann J; Joss A
    Environ Sci Technol; 2010 Aug; 44(16):6024-35. PubMed ID: 20704196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
    Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
    Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceuticals and personal care products in effluent matrices: A survey of transformation and removal during wastewater treatment and implications for wastewater management.
    Oulton RL; Kohn T; Cwiertny DM
    J Environ Monit; 2010 Nov; 12(11):1956-78. PubMed ID: 20938541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.